Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News on Pharma

Flu vaccine now available ahead of 'twindemic' - here is who can get the shot for free

The HSE has made the flu vaccine free to eligible groups in order to curb influenza and Covid-19 infections this winter.

Dublin Live

Morningside Pharmaceuticals sold to Aspire Pharma

In recent years Morningside founder Dr Nik Kotecha OBE has been dedicating time to the Randal Charitable Foundation

Birmingham Post

Girl, 14, speaks out after being denied life-saving prescription refill under Arizona abortion law

“They’re trying to make any girl who’s on this medication drop a pregnancy test when they get their medicine, and I feel like it’s really unfair,” the teen, Emma Thompson, says

The Independent UK

From analysis to the latest developments in health,
read the most diverse news in one place.

The ‘Nang Capital’ WA Wants To Crack Down On Canisters Won’t Someone Pls Think Of The Chefs

"With more young people using the gas... it is important we take steps to protect them."

Pedestrian.tv

NIH to fund unproven ALS drugs under patient-backed law

The U.S. government will soon spend $25 million to help patients access experimental drugs for the incurable illness known as Lou Gehrig's disease

The Independent UK

Zydus gets USFDA approval for generic drug

The drug is used to treat high blood pressure in the lungs

The Hindu

3 Safe Stocks You'll Want to Have Exposure to in 2022

The Fed’s aggressive monetary policies are raising recession fears. Amid such an environment, we think investors could consider adding AbbVie (ABBV), Pfizer (PFE), and Coca-Cola (KO) to their portfolios for stable returns. Read on to learn more….

StockNews.com

Read news from The Economist, FT, and more,
with one subscription

Drug discovery firm e-therapeutics raises £13.5m to fund next stage of growth

The firm, with bases in the North East and South East, also posted interim results in which losses widened

Birmingham Post

Maine Survey Shows Most Voters Want A New Drug Policy Approach That Includes Decriminalization

A recent poll, led by University of Maine professors R. Glover and K. Sporer during July and August 2021 and shared this week, found that of the 400+ Mainers, a majority believe the priority is to treat people who have opioid and general drug use disorders rather than punish them under the…

Benzinga

Psychedelics Without Hallucinations? Study Identifies Possible Antidepressants In LSD-Like Molecules

According to a scientific study pub

Benzinga

ALS drug wins FDA approval despite questionable data

U.S. health officials have approved a much-debated drug to treat the deadly illness known as Lou Gehrig's disease

The Independent UK

PharmaTher Provides Business Highlights And Releases Audited Annual Financials

PharmaTher Holdings Ltd. (OTCQB: PHRRF) has published its operational and audited financial results for fiscal year ended May 31, 2022.

Benzinga

The Best Value Stock to Buy for the Long Term

Biopharmaceutical company Bristol-Myers Squibb (BMY) has reported sound financials and possesses a solid upside potential. Given its promising fundamentals, this value stock might be an ideal long-term addition to your portfolio. Keep reading….

StockNews.com

Pharma manufacturers’ body moves Karnataka HC against treating free samples of medicines given to doctors as ‘freebies’ under Income Tax Act

Ministry of Finance had said that drug manufacturers will have to deduct 10% tax for the value of free samples of medicines

The Hindu

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

Vietnam Law May Impact Facebook, Twitter; Amazon Has A Sleep Tracker; India Lures Apple, Dell, HP: Top Financial Media Stories Thursday, Sept. 29

Reuters

Benzinga

DEA Claims Doctors Requesting Psilocybin For Dying Patients Have Commercial Interests

For the Drug Enforcement Administration (DEA), physicians who seek psilocybin for their dying patients under federal Right to Try (RTT) laws are making a request for a ‘commercial use.’ The DEA is implying that doctors who want to give terminally ill patients psilocybin have a financial interest, making them ineligible for a f

The Hindu

DGCI allows Serum Institute to export malaria vaccine to U.K.

The Drugs Controller General of India (DCGI) has granted permission to send two lakh doses of the vaccine

StockNews.com

2 Earnings Winners to Scoop Up During the Bear Market

The bear market has been brutal. Given the trend in inflation and weakening economy, it's unlikely to end soon. For investors, the best strategy is to use the adverse market conditions to scoop up stocks that have a long-term history of compounding earnings. Therefore, investors should consider buying Builders FirstSource…

Get all your
news in one place.

100's of premium titles.
One news app.

ABC News

Pfizer COVID vaccine approved for all children aged over six months old

The Therapeutic Goods Administration approves Pfizer's paediatric dose of its COVID vaccine for children aged between six months and five years old.

AAP

Interim tick for Pfizer infant booster

The Therapeutic Goods Administration has given provisional approval for Pfizer's COVID-19 booster to be used in children aged six months to five years.

Benzinga

These Stocks Are On The Radar After Biogen-Eisai's Surprising Alzheimer's Trial Win

Eli Lilly And Co (NYSE:LLY) - Market cap: $295 billion.

Businessweek

Lab Monkeys Are the Latest Covid Shortage

Beijing’s ban on macaque exports—needed to test vaccines and other lifesaving drugs—could give its pharma industry an edge.

Benzinga

Why Prothena Corporation Shares Are Trading Higher By 76%, Here Are 53 Stocks Moving In Wednesday's Mid-Day Session

Gainers

Benzinga

7 Biogen Analysts On Alzheimer's Drug Success As Stock Skyrockets 37%

Shares of Biogen Inc (NASDAQ: BIIB) were flying on Wednesday, after the biopharma company said its experimental Alzheimer’s drug with Japanese partner Eisai showed promising results. RBC Capital Markets On Biogen

Tribune News Service

Lawmakers eye lame duck for unfinished business on insulin

WASHINGTON — A bipartisan Senate duo is still working to pass a bill to overhaul insulin prices, but the outlook is complicated by the messy drug pricing system, politics and a busy congressional calendar.

1 … 127 128 129 130

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.